Loyal Valley Capital
Shanghai, Shanghailoyalvalleycapital.com
Overview
Loyal Valley Capital is a thematic, research-driven private equity firm with a strong entrepreneurial culture that invests in companies positioned to benefit from the secular industry transformations in China. The firm mainly focuses on three key sectors: New Consumer, Healthcare, and Advanced Manufacturing. LVC manages capital on behalf of international institutional investors such as sovereign wealth funds, funds of funds, private banks, and family offices, as well as elite entrepreneurs and founders of China's Fortune 500 enterprises.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BriSTAR Immunotech | Jul 2026 | Series C | Lead |
| TrueLab Biopharmaceutical | Jun 2026 | VC Round | Co-investor |
| DeepSeek | Jun 2026 | Early Funding | Co-investor |
| YolTech Therapeutics | May 2026 | Series C | Lead |
| DeepSeek | May 2026 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
